car-t therapy, a novel promising treatment option for chronic hepatitis b and hbv-associated hcc
Published 2 years ago • 3.3K plays • Length 1:33Download video MP4
Download video MP3
Similar videos
-
0:58
evaluating new car constructs for chronic hepatitis b and hbv-associated hcc in the clinic
-
1:12
rationale for using car-ts to treat chronic hepatitis b
-
1:49
a novel subcutaneous car-t therapy for the treatment of hematological malignancies
-
1:34
cctx-001: a novel car-t therapy for aml
-
0:54
ucartcs1: a novel allogeneic car-t therapy for myeloma
-
1:53
scg101: a novel t-cell therapy in advanced hepatitis b-related hcc
-
2:10
managing hematologic toxicity associated with car-t therapy & insights into the car-hematotox score
-
1:06
car-t cell therapy: current applications and how to improve treatment strategies in the future
-
1:55
exploring first-line car-t therapy for the treatment of dlbcl
-
3:10
universal car-t therapy for t-all
-
1:53
phe885, a t-charge manufactured bcma-directed car-t therapy in r/r myeloma
-
1:12
novel all treatment strategies: car t-cells
-
3:41
novel prognosis score for survival in patients with aggressive lymphoma treated with car-t therapy
-
3:33
an overview of the car t-cell therapy story
-
3:43
the future of car-t therapy
-
0:52
nursing and car-t therapy
-
5:25
how to optimize car-t therapy for all
-
1:29
new hnhcp car-t therapy guidelines: an educational resource for nurses and hcps
-
1:01
the potentially curative role of car-t therapy in myeloma